At Oregon Health & Science University — Knight Cancer Institute, I serve as regulatory lead for start-up, maintenance, and close-out across 20–25 oncology studies. I develop plain-language informed consent forms, review protocols before activation, and coordinate FDA expanded access IND packages.
For my Harvard thesis, I designed and led a nationwide qualitative study on existential distress in palliative care, interviewing providers at U.S. cancer centers and analyzing the findings in NVivo. At Dana-Farber Cancer Institute — Phyllis F. Cantor Center, I maintained audit-ready regulatory files and led QC of patient-reported outcome and quality-of-life data.
